Atlas Trials

Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis

Clinical trial NCT02496585 · COMPLETED

Trial details

NCT number
NCT02496585
Sponsor
Memorial Sloan Kettering Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung CancerLung Metastases
Start date
2015-07-08
Primary completion
2024-04-12
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.